Concepedia
Statistics
Publications
37
Citations
2.1K
H-Index
24
Active since
1988
Affiliations
Ipsen (France)(Current)
National Cancer Institute
National Institutes of Health
Naval Medical Research Command
University of Bath
Philip G. Kasprzyk is an author at Ipsen (France) specializing in pharmacology, molecular oncology, and medicine.
Publications per year
1988–2023
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Yoichi Nakanishi, James L. Mulshine, Philip G. Kasprzyk et al. · Journal of Clinical Investigation · 1988 · 251 citations · Full text
Life Sciences, Biochemistry, Oncology +15
Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies.
Philip G. Kasprzyk, Sun U. Song, Pier Paolo Di Fiore et al. · PubMed · 1992 · 151 citations
Medicine, Oncology, Pharmacology +17
Homocamptothecins: Synthesis and Antitumor Activity of Novel E-Ring-Modified Camptothecin Analogues
Olivier Lavergne, Laurence Lesueur‐Ginot, Francesc Pla Rodas et al. · Journal of Medicinal Chemistry · 1998 · 151 citations
Medicine, Medicinal Chemistry, Pharmacology +13
Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
Janendra K. Batra, Philip G. Kasprzyk, Robert E. Bird et al. · Proceedings of the National Academy of Sciences · 1992 · 145 citations
Life Sciences, Biotechnology, Molecular Biology +16
Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
Wolfgang Döhle, Fabrice Jourdan, Grégory Menchon et al. · Journal of Medicinal Chemistry · 2017 · 130 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
1–5 of 37